News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sapphire Therapeutics, Inc. Licenses Novel Drug To Ono Pharmaceutical Company, Ltd. In Japan, Korea And Taiwan For The Treatment Of Cancer Anorexia/Cachexia



10/26/2006 10:27:59 AM

BRIDGEWATER, NJ -- (MARKET WIRE) -- October 26, 2006 -- Sapphire Therapeutics, Inc., a private biopharmaceutical company that develops compounds acting within the ghrelin pathway for metabolic and oncologic diseases, has licensed to Ono Pharmaceutical Co., Ltd. (Osaka, Japan), a novel drug candidate for treating cancer anorexia/cachexia.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES